Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 213049
Company: MSN
Company: MSN
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| THIOTEPA | THIOTEPA | 15MG/VIAL | POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL | Prescription | AP | No | No |
| THIOTEPA | THIOTEPA | 100MG/VIAL | POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL | Prescription | AP | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 03/04/2020 | ORIG-1 | Approval | STANDARD |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/213049Orig1s000ltr.pdf |
Supplements
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
|---|---|---|---|---|---|
| 05/30/2024 | SUPPL-2 | Labeling-Package Insert |
Label is not available on this site. |
THIOTEPA
POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL; 15MG/VIAL
TE Code = AP
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| TEPADINA | THIOTEPA | 15MG/VIAL | POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL | Prescription | Yes | AP | 208264 | ADIENNE SA |
| THIOTEPA | THIOTEPA | 15MG/VIAL | POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL | Prescription | No | AP | 214222 | GLAND |
| THIOTEPA | THIOTEPA | 15MG/VIAL | POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL | Prescription | No | AP | 216037 | MEITHEAL |
| THIOTEPA | THIOTEPA | 15MG/VIAL | POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL | Prescription | No | AP | 213049 | MSN |
| THIOTEPA | THIOTEPA | 15MG/VIAL | POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL | Prescription | No | AP | 217559 | REGCON HOLDINGS |
POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL; 100MG/VIAL
TE Code = AP
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| TEPADINA | THIOTEPA | 100MG/VIAL | POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL | Prescription | Yes | AP | 208264 | ADIENNE SA |
| THIOTEPA | THIOTEPA | 100MG/VIAL | POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL | Prescription | No | AP | 214222 | GLAND |
| THIOTEPA | THIOTEPA | 100MG/VIAL | POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL | Prescription | No | AP | 211755 | HIKMA |
| THIOTEPA | THIOTEPA | 100MG/VIAL | POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL | Prescription | No | AP | 216037 | MEITHEAL |
| THIOTEPA | THIOTEPA | 100MG/VIAL | POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL | Prescription | No | AP | 213049 | MSN |